lu 135252 has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| del Balzo, U; DeMaria, AN; Flaim, SF; Galiuto, L; Iliceto, S; Kirchengast, M; May-Newman, K; Wolf, PL | 1 |
| Alving, K; Gonon, AT; Gourine, AV; Middelveld, RJ; Pernow, J | 1 |
2 other study(ies) available for lu 135252 and Necrosis
| Article | Year |
|---|---|
Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography.
Topics: Animals; Coronary Circulation; Dogs; Endothelin Receptor Antagonists; Hemodynamics; Microcirculation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Ultrasonography | 2000 |
Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion.
Topics: Animals; Antibodies; Blood Pressure; Cardiotonic Agents; Endothelin Receptor Antagonists; Female; Immunohistochemistry; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Peroxidase; Phenylpropionates; Pulmonary Wedge Pressure; Pyrimidines; Receptor, Endothelin A; Receptors, Endothelin; Swine | 2001 |